Where does Schott Pharma Schweiz AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Schott Pharma Schweiz AG ranks #7,769 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Schott Pharma Schweiz AG hold?

Schott Pharma Schweiz AG holds 42 US utility patents granted between 2023 and 2025, spanning 20 technology areas.

What is Schott Pharma Schweiz AG's Innovation Score?

Schott Pharma Schweiz AG has an Innovation Score of 59.2 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Schott Pharma Schweiz AG's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Schott Pharma Schweiz AG.

What does claim depth mean for Schott Pharma Schweiz AG's patents?

Schott Pharma Schweiz AG's patents average 17.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Schott Pharma Schweiz AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Schott Pharma Schweiz AG

Q: What technology areas does Schott Pharma Schweiz AG focus on?

Schott Pharma Schweiz AG's top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 20 patents, ranking #37 of 903 assignees active in that subclass. Grants appear in 20 CPC subclasses total.

USPTO PatentsView assignee record - 42 granted patents across 20 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Schott ranks #7,769 of 49,997 tracked US assignees by granted-patent volume, with 42 patents across 20 technology areas.

#7,769
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.2/100): 17.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7769 · Foreign Corporation #7,769 · 42 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 42 grants
UPPER-Q #7,769/49,997
PHOTO-FINISH Lhoist Recherche et…
CPC-FOCUS A61J · 20 areas
INNOV-PAR 59.2/100
CLAIMS-RICH 17.3 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: S.A. Lhoist Recherche et Développement (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Schott’s 59.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.0 pts (22%) Velocity 20.0 pts (34%) Breadth 15.8 pts (27%) Claim depth 10.4 pts (18%)

Qualcomm Incorporated · highest

85
VMI Holland B V · near

59
Schott Pharma Schweiz · this assignee

59
National Institute… · near

59
NUtech Ventures · near

59
THE Provost Fellows… · near

59
3D Lighting… · lowest

7

What this shows Schott's Innovation Score is 59.2/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Schott?

Each dot is one of Schott’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Schott’s own 17.3 claims/patent is ABOVE the 13.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Schott vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Schott's grants concentrate

Schott Pharma Schweiz AG is a focused PatentsView assignee: 20 CPC subclasses with 47.6% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2024 (22 grants) versus a trough of 11 in 2023. By volume, Schott sits between S.A. Lhoist Recherche et Développement and Shenzhen Relx Technology Co., Ltd..

Schott's three-year grant acceleration

Schott Pharma Schweiz AG shows 33 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Lhoist Recherche…

42
Safilo—SocietÀ Az…

42
Samsung Techwin

42
Santec Holdings

42
SDB IP Holdings

42
Shanghai Bright P…

42
Shenzhen DO Intel…

42
Shenzhen Relx Tec…

42
Schott Pharma Sch… ◀

42

What this shows Schott holds 42 patents at rank #7,767, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Schott

By rank, the assignees closest to #7,767 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Schott's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Schott, neither rank-band nor same-CPC leaders (those blocks stay above). In A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…), Schott ranks #37 of 903 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (59 here).

THE Provost, Fellows, Foundation Scholars, AND THE Other Members OF Board, OF THE College OF THE Holy AND Undivided Trinity OF Queen Elizabeth Near Dublin 59 NUtech Ventures 59 National Institute of Advanced Industrial Science and Technology 59 VMI Holland B.V. 59

Schott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

59 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Schott Pharma Schweiz AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	11	26.2%
2024	22	52.4%
2025partial year	9	21.4%

Which technologies does Schott Pharma Schweiz AG patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 20

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 20

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 17

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 12

C03B - Manufacture, Shaping, OR Supplementary Processes 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 3

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

C08L - Compositions OF Macromolecular Compounds 2

B65G - Transport OR Storage Devices, e.g. Conveyors FOR Loading OR Tipping, Shop Conveyor Systems OR Pneumatic Tube Conveyors 2

C03C - Chemical Composition OF Glasses, Glazes OR Vitreous ENAMELS; Surface Treatment OF GLASS; Surface Treatment OF Fibres OR Filaments Made From Glass, Minerals OR SLAGS; Joining Glass TO Glass OR Other Materials 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

Y10T - Technical Subjects Covered BY Former US Classification 1

B23B - TURNING; Boring 1

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

Top 15 of 20 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Schott Pharma Schweiz AG's patent record in context - here's where to go next.

Schott Pharma Schweiz AG's lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 47.6% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #7,769 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Schott Pharma Schweiz AG against S.A. Lhoist Recherche et Développement, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.